Back to HALO
Swedbank AB HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
8
Latest value
$30K
Q3 2026
Peak value
$17.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $10.9M |
| Q4 2025 | $10.9M |
| Q1 2026 | $10.4M |
| Q1 2026 | $3K |
| Q2 2026 | $15.8M |
| Q2 2026 | $4K |
| Q3 2026 | $17.1M |
| Q3 2026 | $30K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $30K | 270 | — | — |
| Q3 2026 | $17.1M | 155.1K | — | — |
| Q2 2026 | $4K | 50 | — | — |
| Q2 2026 | $15.8M | 202.4K | — | — |
| Q1 2026 | $3K | 50 | — | — |
| Q1 2026 | $10.4M | 160.7K | — | — |
| Q4 2025 | $10.9M | 162.1K | — | — |
| Q4 2025 | $10.9M | 162.1K | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$251.9M
$236.6M
$176.7M
$148.6M